Top Tweets for #AlconScience
Corneal sensory nerves detect environmental stimuli and regulate tear secretion, highlighting their potential as novel targets for #DryEye disease (DED) therapies. Discover more about the science behind DED at https://t.co/H8jAPK1aaH #AlconScience #MedicalAffairs
Attention #EyeCare Professionals: You can now find our entire library of #AlconScience videos on #Eyetube! New content is added regularly—explore the portal often to stay informed on the science driving every #AlconInnovation: https://t.co/3RGFyVjPhI
Despite current #DryEye disease (DED) pharmaceutical treatment options, there is still a significant unmet need for new DED therapeutics with novel targets and mechanisms of action. Get to know more about the science behind DED at https://t.co/yBmRCVrZWD #AlconScience
Do lens decentration and/or tilt impact vision quality after #CataractSurgery with CLAREON® Vivity® extended-depth-of-focus intraocular lenses (EDOF IOLs)? Watch the full video on #AlconScience.com to find out: https://t.co/eUbMkbzBJl
In this video, Dr. Rajesh Shetty introduces a recent study, which analyzed the relationship between CLAREON® Vivity® IOL decentration/tilt and:
➡️ Monocular best-corrected distance visual acuity
➡️ Monocular distance-corrected visual acuity at intermediate and distance
➡️ Uncorrected distance visual acuity
➡️ Manifest refraction spherical equivalent
Check out the full video from the #Alcon #GlobalMedicalAffairs team at the link above for details and outcomes from the study, titled Effect of IOL Centration and Tilt on Visual Performance of a Non-diffractive EDOF.
#MedicalAffairs #ClinicalStudy
We are excited to introduce ALMI (Alcon Medical Information), our new virtual chatbot from Alcon US Medical Affairs, designed to provide healthcare professionals with fast, reliable answers to frequently asked questions about Alcon’s products.
Now available on our #AlconScience website, ALMI offers a streamlined, accessible way to engage with product-related inquiries.
✅24/7 access to FAQs about Alcon’s product portfolio
✅Reduced wait times and improved user experience for #HCPS
✅Consistent, compliant responses that support scientific exchange
Connect with ALMI today: https://t.co/2kErJ2oq25 #MedicalAffairs
#DigitalHealth #MedicalInformation #Chatbot #AlconScience #MedicalAffairs #AlconUS
How does the micro-monovision approach impact visual outcomes after #CataractSurgery? Watch the study summary with Dr. Dagny Zhu on #AlconScience.com to find out ➡️https://t.co/V3siFCTO6I⬅️
CLAREON® Vivity® extended-depth-of-focus intraocular lenses (EDOF IOLs) are designed to minimize the incidence of visual disturbances while providing good distance and intermediate and functional near vision. Some surgeons seek to further increase that range of vision — as well as spectacle independence — by implanting slightly myopic in the non-dominant eye.
Dr. Zhu evaluated the effects of this micro-monovision technique in a recent study: Visual Outcomes and Patient Satisfaction after Bilateral Implantation of a Non-diffractive EDOF IOL Made of an Advanced Hydrophobic Acrylic Material. She implanted CLAREON® Vivity® IOLs, targeting plano in the dominant eye and -0.25D in the non-dominant eye.
The results: 3 months post-op, excellent ~20/20 binocular uncorrected distance and intermediate VA ,and ~20/25 uncorrected near VA with low incidence of visual disturbances.
Check out the full video from the #Alcon #GlobalMedicalAffairs team via the link above to learn about patient satisfaction, visual disturbance and spectacle independence outcomes.
#MedicalAffairs #ClinicalStudy
#AlconScience is now on #Eyetube! From #EyeSurgery techniques and clinical cases to insights from global experts, Eyetube is THE leading video platform for eye care professionals. And now there’s yet another reason to check it out: The #AlconScience portal.
Visit now ➡️ https://t.co/NM7vgSxy5p ⬅️ to see peer perspectives, clinical insights, study results and technology overviews across a wide range of therapeutic areas. Be sure to bookmark the Alcon Science portal to stay up-to-date on our latest additions.
#EyeCare #Alcon #GlobalMedicalAffairs
We’re excited to have our #GlobalMedicalAffairs team join leaders in #Optometry @aaopt — The American Academy of Optometry Annual Meeting — October 8–10 in Boston. They’ll be sharing the latest #AlconScience clinical insights, discussing advancements, and connecting with peers.
Visit us at Booth #916 to explore the science behind Alcon’s latest innovations, and don’t miss our symposia and Scientific Exchange presentations.
Our symposia will feature evidence-based insights from Alcon experts and invited researchers — with focused discussions on new therapeutic approaches in #DryEyeDisease and advances in #Glaucoma management.
We’ll also host Scientific Exchange sessions covering the latest in innovation across #EyeCare.
If you're attending, be sure to connect with the GMA team for more information around our presence at #Academy2025 — including details on our symposia, scientific exchange presentations, and more.
Academy advances optometry and vision science by driving education, research, and collaboration. Through our support, Alcon is committed to turning science into high-quality patient care — helping people #SeeBrilliantly.
We look forward to seeing you in Boston!
Interested in submitting a clinical research proposal to the Alcon Investigator-Initiated Trial (IIT) Program? Learn about our IIT process and areas of therapeutic interest here: https://t.co/MOWxhsIIZ8
#AlconScience #MedicalAffairs
How does axial length measurement method affect various intraocular lens (IOL) power calculation formulas—and refractive outcomes after #CataractSurgery? #Alcon Global Medical Affairs investigates in this in-depth white paper: https://t.co/l9M65W03BT
#Ophthalmology #AlconScience
From #Glaucoma and #ContactLenses to #CataractSurgery and #LASIK, Alcon is looking to support research across a range of therapeutic areas as part of our Investigator-Initiated Trial Program. Learn more here: https://t.co/MOWxhsIIZ8
#AlconScience #MedicalAffairs
Sign up for our #ESCRS2025 scientific exchange presentations! Register now to attend any of our 5 presentations — each with multiple sessions to choose from: https://t.co/vxtVy1kzuJ Visit the #Alcon #GlobalMedicalAffairs team at booth C2.033 to learn more. #AlconScience
In long eyes, axial length measured via Mean Group Refractive Index is up to 0.15 mm longer than when measured via the Sum-of-Segments (SOS) method—and every 0.1 mm difference affects final refraction by 0.2 D.* Read our full analysis here: https://t.co/e7yD8ZsPmI
#AlconScience
Through our Investigator-Initiated Trial Program, #Alcon proudly supports clinical research that is aligned with our areas of therapeutic interest. Learn whether you qualify and how to get started here: https://t.co/MOWxhsIIZ8
#AlconScience #MedicalAffairs
Thank you to everyone who connected with the #Alcon #GlobalMedicalAffairs team at #APACRS2025. Visit our #AlconScience site to learn even more about the latest clinical insights behind all of our #CataractSurgery innovations: https://t.co/n9IkIsRqgx
#ESCRS2025 is right around the corner! We are so excited for this opportunity to share the latest advances in #ophthalmology and connect with fellow experts. If you’re attending, visit the #Alcon #GlobalMedicalAffairs team at booth C2.033: https://t.co/vxtVy1kzuJ #AlconScience
In recent phase 3 clinical trials, acoltremon 0.003% ophthalmic solution demonstrated effectiveness in increasing tear production. For more information about acoltremon ophthalmic solution 0.003%, visit https://t.co/kZa6ziG5hA. https://t.co/vBFp33vR7G
#AlconScience #Innovation
Add #AlconScience Science on #Eyetube to your phone’s home screen for quick access to expert videos and research. Tap “Add to Home Screen” to keep Alcon Science Eyetube just one click away. #MedicalAffairs
Visit Alcon Science on Eyetube: https://t.co/VnwSD4XtbL
Planning to attend #APACRS2025? Visit our #Alcon #GlobalMedicalAffairs team at booth A1! This year’s theme, Learning from the Masters, perfectly captures our mission to share the latest scientific innovations in #CataractSurgery. https://t.co/n9IkIsRqgx #AlconScience
Attention clinical researchers: Whether you practice in a private setting or an academic center, we welcome the opportunity to connect regarding our #Alcon Investigator-Initiated Trial Program. Learn more here: https://t.co/MOWxhsIIZ8
#AlconScience #MedicalAffairs
Last Seen Hashtags on Sotwe
spanking
Seen from Korea
gaybukkake
Seen from United Kingdom
아줌마
Seen from Korea
marian franco
Seen from Mexico
countryhumansnsfw #CountryHumansjapanempire
Seen from United States
Uzidoorman #Rule34
Seen from United States
weights
Seen from United States
yerimuavideo
Seen from Mexico
NoLimit
Seen from Canada
Latina #slut
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
240.4M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.4M followers
Taylor Swift
@taylorswift13
81.2M followers
Lady Gaga
@ladygaga
72.8M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.5M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.7M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.2M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.5M followers